Focused : Actualité Focused en direct - P8 | Bourse Reflex
Accueil > Tags > Focused

  • Toutes les actualités en rapport avec « Focused »

21/06 14:05 Focused - Crucial Further Expands Gaming Line with New Ballistix Tactical and Ballistix Elite Series

20/06 10:00 Focused - Pluristem and United Therapeutics Enter Into an Exclusive License Agreement to Develop and Commercialize PLX Cells for the Treatment of Pulmonary Hypertension

20/06 08:35 Focused - Apricus Biosciences' CEO Sees Higher Revenue if Pfizer Viagra(R) Litigation is Successful

14/06 14:35 Focused - Competitive Technologies, Inc. Increased Number of Directors; Appointed New Board Member

13/06 11:15 Focused - Richmond Capital Outsources Fund Administration and Key Operational Services to SSandC

03/06 15:00 Focused - Apricus Biosciences Appoints Steve Martin as Senior Vice President and Chief Financial Officer

03/06 14:00 Focused - Competitive Technologies to Exhibit Calmare(R) Pain Therapy Device at American Society of Clinical Oncology Annual Meeting June 3-7, 2011

03/06 14:00 Focused - Apricus Bio CEO to Present Commercialization Plans for Vitaros(R) at Jefferies 2011 Global Healthcare Conference

31/05 16:50 Focused - Apricus Biosciences Announces Issuance of Key Patent for RayVa(TM) for Raynaud's Phenomenon in Israel

31/05 09:00 Focused - Veritas Asset Management Goes Live With SSandC's Recon(TM)

30/05 18:00 Focused - 2010-11 CONSOLIDATED RESULTS : 20.1% increase in current operating income; 29% reduction in net debt to EUR 66 million

27/05 11:00 Focused - Apricus Biosciences' CEO to Present at Jefferies 2011 Global Healthcare Conference

24/05 09:05 Focused - Innovative New i-PWER(TM) Low Profile Modular Power Supply Family Launched for Industrial and Communication Markets

24/05 08:55 Focused - Apricus Biosciences to Present at the Euro-Biotech Partnering Forum 2011 to Further Its Partnership Efforts

20/05 17:20 Focused - Competitive Technologies Announces Financial Results for Quarter Ended March 31, 2011

20/05 16:10 Focused - Apricus Biosciences Will Request Approval of Vitaros(R) as a Treatment for Erectile Dysfunction in Switzerland, Based on Guidance From Swiss Regulatory Authorities

20/05 16:00 Focused - Apricus Biosciences CEO is Interviewed on CDTV.net

20/05 13:35 Focused - Melco Crown Entertainment Limited Announces the Closing of Its RMB-Denominated Bond Offering

19/05 14:45 Focused - Apricus Biosciences Receives Guidance From Swiss Regulatory Authorities Regarding Filing for Market Authorization of Vitaros(R) for Erectile Dysfunction in Switzerland

13/05 18:30 Focused - Q1-2011 Sales information